Welcome to Labeled Immunoassays and Clinical Medicine website!

The Feasibility of 153Sm Labeled Cytosine in Tumor Imaging

Expand
  • Tianjin University of Traditional Chinese Medicine, Tianjin 300193,China

Received date: 2014-11-13

  Revised date: 2015-02-28

  Online published: 2015-04-22

Abstract

Abstract: Objective To investigate the application of 153Sm labeled cytosine in tumor metabolic imaging. Methods The cytosine was labeled with 153Sm by DTPA coupled method, the final product was C-DTPA-153Sm. The labeled product was then purified. The determination of acute toxicity, in vitro stability, plasma pharmacokinetics in rabbits and imaging of cell and in tumor-bearing mice of radiolabeled cytosine were carried out. Results The results of examinations and animal experiments showed that the C-DTPA-153Sm was free of bacteria, pyrogen and toxic agents, and it could be concentrated at the tumor site in tumor-bearing mice. Conclusion C-DTPA-153Sm metabolic imaging might be used to evaluate the tumor growing status and may have important clinical value.

Cite this article

NIU Jing-xiu, HE Jing-hua, LIU Jiang, CHANG Ke-li, ZHU Dian-qing, PANG Yan, LI Wei-lian . The Feasibility of 153Sm Labeled Cytosine in Tumor Imaging[J]. Labeled Immunoassays and Clinical Medicine, 2015 , 22(3) : 211 . DOI: 10.11748/bjmy.issn.1006-1703.2015.03.017

Outlines

/